Reaching at-risk women for PrEP delivery: What can we learn from clinical trials in sub-Saharan Africa?

ABSTRACT:

Introduction

ARV-based pre-exposure prophylaxis (PrEP) has the potential to avert many new HIV infections, yet little is known about how to reach women at high risk for HIV infection and motivate them to initiate PrEP. Clinical trials have succeeded in recruiting at-risk participants, evidenced by control arm HIV incidence ≥3% (defined by the World Health Organization as "substantial risk"). We examined experiences from HIV prevention trials to document recruitment strategies and identify practical, potentially effective strategies for reaching women in real-world PrEP delivery.

Methods

We conducted semi-structured qualitative phone interviews with 31 staff from five countries who had worked on one or more of seven ARV-based HIV prevention clinical trials. Questions explored

SUBMITTER: Stankevitz K 

PROVIDER: S-EPMC6588242 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature